Prosecution Insights
Last updated: November 12, 2026

Pioneura Corporation

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Pioneura Corporation has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is being processed by 1 distinct examiner in 1 distinct art unit. The use of 1 distinct art unit indicates that the biotechnology claims are being evaluated within a specific examination group, which may provide a consistent technical baseline for the review.

HABTE, KAHSAY is the busiest examiner for the company, managing 1 pending office action. This single action represents the full extent of the company's current pending matters at the patent office. Because the portfolio is limited to 1 distinct examiner and 1 distinct art unit, the prosecution path is highly streamlined. Practitioners can focus their efforts on the specific examination style of HABTE, KAHSAY for this biotechnology filing.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HABTE, KAHSAY 1 84.9% +7.5%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18779948 ACID ADDITION SALTS, COMPOSITIONS, AND METHODS OF TREATING THEREOF HABTE, KAHSAY —

Top Art Units

Art UnitApps
1624 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18779948 ACID ADDITION SALTS, COMPOSITIONS, AND METHODS OF TREATING THEREOF HABTE, KAHSAY 1624 §103Other Non-Final OA — Pending Jul 22, 2024

Managing Pioneura Corporation's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Pioneura Corporation have?

Pioneura Corporation has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Pioneura Corporation applications?

Kahsay Habte has the most, with 1 of Pioneura Corporation's pending office actions.

What technology area are Pioneura Corporation's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month